Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

NCT05169203 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT05169203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05169203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
January 1, 2021
Enrollment
2,969 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, diffuse large b-cell lymphoma cell of origin, diffuse large b-cell lymphoma recurrent